Search Result

Results for "

1c

" in MedChemExpress (MCE) Product Catalog:

By Targets:	17β-HSD (1) 5-HT Receptor (15) ADC Linker (5) Adrenergic Receptor (1) Aldose Reductase (5) Antibiotic (1) Apoptosis (11) Autophagy (1) Bacterial (8) Biochemical Assay Reagents (3) c-Fms (1) c-Kit (1) c-Met/HGFR (2) Calcium Channel (2) Casein Kinase (1) CCR (4) Complement System (6) DNA Alkylator/Crosslinker (2) DNA/RNA Synthesis (9) Dopamine Receptor (2) E3 Ligase Ligand-Linker Conjugates (6) EGFR (2) Endogenous Metabolite (31) Enteropeptidase (1) ERK (2) FGFR (1) Fluorescent Dye (4) FXR (2) GLP Receptor (2) Hexokinase (1) Histamine Receptor (1) HIV (1) HSV (1) IKK (1) Influenza Virus (2) Interleukin Related (1) Isotope-Labeled Compounds (40) LPL Receptor (1) LXR (1) MEK (1) Melatonin Receptor (1) Microtubule/Tubulin (1) Mitophagy (1) mTOR (1) Na+/K+ ATPase (1) NF-κB (1) Nucleoside Antimetabolite/Analog (5) Orthopoxvirus (1) PAI-1 (1) PAK (1) Parasite (1) PARP (1) Phosphatase (2) Phosphodiesterase (PDE) (8) Phospholipase (1) PI3K (1) PIKfyve (1) Pim (1) Potassium Channel (2) PROTAC Linkers (23) Proteasome (1) Raf (1) Ras (1) Reactive Oxygen Species (3) RXFP Receptor (1) Ser/Thr Protease (1) Small Interfering RNA (siRNA) (36) Sodium Channel (2) VEGFR (1)
By Research Areas:	Cancer (93) Cardiovascular Disease (9) Endocrinology (3) Infection (8) Inflammation/Immunology (22) Metabolic Disease (19) Neurological Disease (36)
Click Chemistry:	ADC Synthesis (1) DBCO (1) PROTAC Synthesis (6) Azide (5) Alkynes (1)

249

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

106

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-139598

LFHP-1c	Phospholipase	Cardiovascular Disease
LFHP-1c is an PGAM5 inhibitor with neuroprotective activity in brain ischemic stroke. LFHP-1c protects blood-brain barrier integrity from ischemia-induced injury. LFHP-1c binds to endothelial PGAM5 to inhibit the activity of PGAM5 phosphatase and the interaction of PGAM5 with NRF2. LFHP-1c exhibits in vitro and in vivo protection ^[1].

HY-17429

Flecainide acetate R-818	Sodium Channel	Cardiovascular Disease
Flecainide acetate (R-818) is a class 1C antiarrhythmic agent especially used for the management of supraventricular arrhythmia; works by blocking the Nav1.5 sodium channel in the heart, causing prolongation of the cardiac action potential.

HY-N11537

2-Methoxy-6-pentadecyl-1,4-benzoquinone	Others	Others
2-Methoxy-6-pentadecyl-1,4-benzoquinone (1c) is a pentadecyl derivative that can be isolated from seed oils of different iris plants such as I. pseudacorus, I. missouriensis and I. sibirica ^[1].

HY-U00374

Sch59498

Phosphodiesterase (PDE) Neurological Disease

Sch59498 is a potent inhibitor of phosphodiesterase 1c (Pde1c).

Sch59498	Phosphodiesterase (PDE)	Neurological Disease
Sch59498 is a potent inhibitor of phosphodiesterase 1c (Pde1c).

HY-147931

Human enteropeptidase-IN-2	Enteropeptidase	Metabolic Disease
Human enteropeptidase-IN-2 (compound 1c) is a highly potent enteropeptidase inhibitor. Human enteropeptidase-IN-2 can be used for anti-obesity research ^[1].

HY-148087

AZD5462	RXFP Receptor	Cardiovascular Disease
AZD5462 is a *RXFP1* modulator, can be used for heart failure research. *RXFP1* is the cognate receptor for human relaxin, belongs to GPCR family 1c number with anti-fibrotic and anti-inflammatory properties ^[1].

HY-100980

HEAT hydrochloride BE2254 hydrochloride	Adrenergic Receptor	Neurological Disease
HEAT (BE2254) hydrochloride is a selective _{alpha 1 adrenergic receptor} antagonist. HEAT hydrochloride, a phenethylamine derivative, shows pK_is of 9, 9.1, and 8.57 for alpha 1a, alpha 1b and alpha 1c, respectively ^[1] .

HY-P99614

Fazpilodemab BFKB8488A	FGFR	Metabolic Disease
Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD) ^[1].

HY-148326

Glu(OtBu)-Val-Cit-PAB-OH	ADC Linker	Others
Glu(OtBu)-Val-Cit-PAB-OH (compound L5-1c) is an non-cleavable ADC linker. Glu(OtBu)-Val-Cit-PAB-OH has been used to synthesis protein-tubulysin conjugates ^[1].

HY-149900

Antiviral agent 33	Biochemical Assay Reagents	Infection
Antiviral agent 33 (compound 1c) is a double-stranded DNA (dsDNA) virus inhibitor with IC₅₀ values of 0.0790 and 0.1572 µM for VACV and AdV5, respectively. Antiviral agent 33 also has potential for oral administration ^[1].

HY-113567

GSK2324	FXR	Metabolic Disease
GSK2324 (Compd 1c) is a FXR agonist for diabetes study, with an EC₅₀ of 120 nM. GSK2324 exhibits t_1/2 values of 84 min (mouse), 170 min (rat), 110 min (beagle) and 120 min (cyno), respectively ^[1].

HY-B0061

Tandospirone citrate 2 Publications Verification SM-3997 citrate	5-HT Receptor	Neurological Disease
Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM).

HY-N1967

Dihydrocurcumin
Dihydrocurcumin, a major metabolites of curcumin, reduces lipid accumulation and oxidative stress. Dihydrocurcumin regulates mRNA and protein expression levels of SREBP-1C, PNPLA3 and PPARα, increases protein expression levels of pAKT and PI3K, and reduced the levels of cellular NO and ROS via Nrf2 signaling pathways ^[1].

HY-143768

Cap-dependent endonuclease-IN-14	Influenza Virus	Infection
Cap-dependent endonuclease-IN-14 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-14 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-14 has the potential for the research of viral infections caused by influenza viruses (extracted from patent CN113620948A, compound 1-c) ^[1].

HY-17429S

Flecainide-d4 acetate R-818-d₄	Sodium Channel	Cardiovascular Disease
Flecainide-d₄ (acetate) is the deuterium labeled Flecainide acetate. Flecainide acetate (R-818) is a class 1C antiarrhythmic agent especially used for the management of supraventricular arrhythmia; works by blocking the Nav1.5 sodium channel in the heart, causing prolongation of the cardiac action potential[1][2].

HY-111820

CK1-IN-1	Casein Kinase	Inflammation/Immunology
CK1-IN-1 is a casein kinase 1 (CK1) inhibitor extracted from patent WO2015119579A1, compound 1c, has IC₅₀s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε, p38σ MAPK, respectively ^[1].

HY-123402

GSK3987	LXR	Metabolic Disease
GSK3987 is a pan LXRα/β agonist with EC₅₀s of 50 nM, 40 nM for LXRα-SRC1 and LXRβ-SRC1, respectively. GSK3987 increases the expression of ABCA1 and SREBP-1c. GSK3987 induces cellular cholesterol efflux and triglyceride accumulation ^[1].

HY-146495

Antitubercular agent-19	Bacterial	Infection
Antitubercular agent-19 (Compound 1c) is an antitubercular agent. Antitubercular agent-19 shows excellent activity against MTB H37Rv and MDR-MTB strains (MIC: ＜0.016 µg/ml). Antitubercular agent-19 shows low cytotoxicity and relatively high acute lethal toxicity in BALB/c mice ^[1].

HY-155124

Antiproliferative agent-32	Apoptosis	Cancer
Antiproliferative agent-32 (Compound 1c) inhibits the phosphorylation of PI3K/Akt/mTOR signaling pathway. Antiproliferative agent-32 inhibits Huh7 and SK-Hep-1 cells proliferation, and induce cells apoptosis, causes mitochondrial damage. Antiproliferative agent-32 can be used for research of hepatocellular carcinoma ^[1].

HY-136569

DSR-141562	Phosphodiesterase (PDE)	Neurological Disease
DSR-141562 is a novel, orally active, and selective brain-penetrant phosphodiesterase 1 (PDE1) inhibitor. DSR-141562 shows preferential selectivity for human PDE1B with an IC₅₀ of 43.9 nM, and the IC₅₀ values for human PDE1A and 1C are 97.6 and 431.8 nM, respectively. DSR-141562 can be used for the study of positive symptoms, negative symptoms and cognitive impairments associated with schizophrenia ^[1] .

HY-160267

iPAF1C

DNA/RNA Synthesis HIV Infection

iPAF1C is a potent inhibitor of polymerase-associated factor 1 complex (PAF1C). iPAF1C has anti-HIV activity ^[1].

iPAF1C	DNA/RNA Synthesis HIV	Infection
iPAF1C is a potent inhibitor of polymerase-associated factor 1 complex (PAF1C). iPAF1C has anti-HIV activity ^[1].

HY-P3418

CKLF1-C27	CCR ERK	Inflammation/Immunology
CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates *ERK1/2* pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research ^[1].

HY-P3982

CKLF1-C19	CCR	Inflammation/Immunology
CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). CKLF1-C19 interacts with CCR4, and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 can suppress allergic lung inflammation via inhibiting chemotaxis mediated by CCR3 and CCR4 ^[1].

HY-P3418A

CKLF1-C27 TFA	CCR ERK	Inflammation/Immunology
CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates *ERK1/2* pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research ^[1].

HY-157810

AKR1C3-IN-11	Aldose Reductase	Cancer
AKR1C3-IN-11 (Compound 6e) is a Aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC₅₀ of 2.0 μM. AKR1C3-IN-11 inhibit cell proliferation in combination with abiraterone (HY-70013). AKR1C3-IN-11 can be used for the research of prostate cancer ^[1].

HY-146573

AKR1C3-IN-6	Others	Cancer
AKR1C3-IN-6 (Compound 1) is a potent, selective *AKR1C3* inhibitor with IC₅₀ values of 0.31 μM and 73.23 μM against AKR1C3 and *AKR1C2, respectively. AKR1C*3-IN-6 shows antitumor activity ^[1].

HY-163323

AKR1C3-IN-12	Aldose Reductase	Cancer
AKR1C3-IN-12 (compound 2j) is an aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC₅₀ of 27 nM. AKR1C3-IN-12 enhances the efficacy of Gemcitabine and Cisplatin in bladder cancer ^[1].

HY-138557

AKR1C3-IN-4	17β-HSD	Cancer
AKR1C3-IN-4 is a potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitor with an IC₅₀ of 0.56 μM. AKR1C3-IN-4 has the potential for castrate resistant prostate cancer (CRPC) research ^[1].

HY-131043

NVS-PAK1-C	PAK	Cancer
NVS-PAK1-C is a potent, ATP-competitive and specific allosteric *PAK1* inhibitor probe with IC₅₀ values of 5 nM and 6 nM for dephosphorylated PAK1 and phosphorylated PAK1, respectively. NVS-PAK1-C is also against dephosphorylated PAK2 (IC₅₀=270 nM) and phosphorylated PAK2 (IC₅₀=720 nM) ^[1].

HY-146574

AKR1C3-IN-7

Others Cancer

AKR1C3-IN-7 (Compound 13) is a potent, selective AKR1C3 inhibitor with an IC₅₀ of 0.19 μM. AKR1C3-IN-7 shows antitumor activity ^[1].
HY-146575

AKR1C3-IN-8

Others Cancer

AKR1C3-IN-8 (Compound 5) is a potent, selective AKR1C3 inhibitor with an IC₅₀ of 0.069 μM. AKR1C3-IN-8 shows antitumor activity ^[1].

AKR1C3-IN-7	Others	Cancer
AKR1C3-IN-7 (Compound 13) is a potent, selective *AKR1C3* inhibitor with an IC₅₀ of 0.19 μM. AKR1C3-IN-7 shows antitumor activity ^[1].

AKR1C3-IN-8	Others	Cancer
AKR1C3-IN-8 (Compound 5) is a potent, selective *AKR1C3* inhibitor with an IC₅₀ of 0.069 μM. AKR1C3-IN-8 shows antitumor activity ^[1].

HY-152188

AKR1C3-IN-9	Aldose Reductase	Cancer
AKR1C3-IN-9 is a selective inhibitor of Aldo-keto Reductase 1C3 (AKR1C3) with an IC₅₀ value of 8.92 nM. AKR1C3-IN-9 significantly reverses the Doxorubicin (HY-15142A) (DOX) resistance in a resistant breast cancer cell line ^[1].

HY-155502

AKR1C3-IN-10	Aldose Reductase	Cancer
AKR1C3-IN-10 (compound 5r) is a selective *AKR1C3* inhibitor (IC₅₀=51 nM). AKR1C3-IN-10 shows good activity in a prostate cancer xenograft model ^[1].

HY-114009

AKR1C1-IN-1

Others Neurological Disease

AKR1C1-IN-1 is a potent and selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1), with a K_i value of 4 nM for AKR1C1 ^[1].
HY-107379

AKR1C3-IN-1

Others Others

AKR1C3-IN-1 is a potent, highly selective inhibitor of AKR1C3, with an IC₅₀ of 13 nM.

AKR1C1-IN-1	Others	Neurological Disease
AKR1C1-IN-1 is a potent and selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1), with a K_i value of 4 nM for AKR1C1 ^[1].

AKR1C3-IN-1	Others	Others
AKR1C3-IN-1 is a potent, highly selective inhibitor of *AKR1C3, with an IC₅₀* of 13 nM.

HY-149028

Mem-C1C18	Fluorescent Dye	Others
Mem-C1C18 is a polarity-sensitive fluorescent probe with excellent plasma membrane anchoring, high brightness and a sensitive response to environmental polarity by altering the fluorescence lifetime. Mem-C1C18 can be used to quantify changes in the polarity of the plasma membrane during iron death ^[1].

HY-144749

AKR1C3-IN-5	Others	Cancer
AKR1C3-IN-5 (Compound 6e) is a potent inhibitor of *AKR1C3. AKR1C3 enzyme is overexpressed in hormone-dependent prostate and breast tumors. AKR1C3-IN-5 derived from drupanin, which exhibits half-maximal inhibitory concentration (IC₅₀*) of 9.6 ± 3 μM and selectivity index (SI) of 5.5 against MCF-7 cells ^[1].

HY-140002

Amino-PEG1-C2-acid

PROTAC Linkers Cancer

Amino-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].
HY-140541

Tri-(PEG1-C2-acid)

PROTAC Linkers Cancer

Tri-(PEG1-C2-acid) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Amino-PEG1-C2-acid	PROTAC Linkers	Cancer
Amino-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Tri-(PEG1-C2-acid)	PROTAC Linkers	Cancer
Tri-(PEG1-C2-acid) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

HY-162275

JMJD1C-IN-1	Others	Cancer
JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis ^[1].

HY-140009

Azido-PEG1-C2-acid	PROTAC Linkers	Cancer
Azido-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1]. Azido-PEG1-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-157750

MEK1/C-Raf-IN-1

MEK Raf Cancer

MEK1/C-Raf-IN-1 (Compound 14d) is a MEK1/C-Raf inhibitor with IC₅₀ values of 97 and 23 nM, respectively. MEK1/C-Raf-IN-1 has antitumor activity ^[1].
HY-140013

Fmoc-NH-PEG1-C2-acid

PROTAC Linkers Cancer

Fmoc-NH-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].
HY-140479

Acid-PEG1-C2-Boc

PROTAC Linkers Cancer

Acid-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].
HY-141364

Bromo-PEG1-C2-Boc

PROTAC Linkers Cancer

Bromo-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].
HY-130758

Ald-PEG1-C2-Boc

PROTAC Linkers Cancer

Ald-PEG1-C2-Boc is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

MEK1/C-Raf-IN-1	MEK Raf	Cancer
MEK1/C-Raf-IN-1 (Compound 14d) is a *MEK1/C-Raf* inhibitor with IC₅₀ values of 97 and 23 nM, respectively. MEK1/C-Raf-IN-1 has antitumor activity ^[1].

Fmoc-NH-PEG1-C2-acid	PROTAC Linkers	Cancer
Fmoc-NH-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Acid-PEG1-C2-Boc	PROTAC Linkers	Cancer
Acid-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Bromo-PEG1-C2-Boc	PROTAC Linkers	Cancer
Bromo-PEG1-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Ald-PEG1-C2-Boc	PROTAC Linkers	Cancer
Ald-PEG1-C2-Boc is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

HY-140819

Bromo-PEG1-C2-azide	PROTAC Linkers	Cancer
Bromo-PEG1-C2-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1]. Bromo-PEG1-C2-azide is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-140221

Azido-PEG1-C2-methylamine	PROTAC Linkers	Cancer
Azido-PEG1-C2-methylamine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1]. Azido-PEG1-C2-methylamine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-140792

Azido-PEG1-C1-Boc	PROTAC Linkers	Cancer
Azido-PEG1-C1-Boc is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs ^[1]. Azido-PEG1-C1-Boc is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-141116

Boc-N-PEG1-C2-NHS ester

PROTAC Linkers Cancer

Boc-N-PEG1-C2-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1].

Cat. No.	Product Name	Target	Research Area

HY-P3418

CKLF1-C27	CCR ERK	Inflammation/Immunology
CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates *ERK1/2* pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research ^[1].

HY-P3982

CKLF1-C19	CCR	Inflammation/Immunology
CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). CKLF1-C19 interacts with CCR4, and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 can suppress allergic lung inflammation via inhibiting chemotaxis mediated by CCR3 and CCR4 ^[1].

HY-P1925A

GO-203 TFA 2 Publications Verification	PI3K Reactive Oxygen Species Apoptosis	Cancer
GO-203 TFA is a potent *MUC1-C* oncoprotein inhibitor. GO-203 TFA is an all D-amino acid peptide that consists of a poly-R transduction domain linked to a CQCRRKN motif that binds to the MUC1-C cytoplasmic tail and blocks MUC1-C homodimerization. GO-203 TFA downregulates TIGAR (TP53-induced glycolysis and apoptosis regulator) protein synthesis by inhibiting the *PI3K-AKT-S6K1* pathway. GO-203 TFA induces the production of ROS and loss of mitochondrial transmembrane potential. GO-203 TFA inhibits the growth of colon cancer cells in vitro and as xenografts in nude mice ^[1] .

HY-P3418A

CKLF1-C27 TFA	CCR ERK	Inflammation/Immunology
CKLF1-C27, a C-terminal peptide of CKLF1, binds to CCR4 receptor and activates *ERK1/2* pathway. CKLF1-C27 can abrogate the effect of CKLF1 on cells by competing for CCR4 receptor. CKLF1-C27 shows great effect on promoting proliferation on HUVECs. CKLF1-C27 has the potential for psoriasis research ^[1].

HY-P4664

VHLTP	Peptides	Inflammation/Immunology
VHLTP is the N-terminal pentapeptide of human hemoglobin beta. VHLTP binds to cell membranes and serves as a ligand for anti-HbA1c antibodies ^[1].

HY-P1925B

L-GO-203 TFA

Peptides Cancer

L-GO-203 TFA is a potent MUC1-C oncoprotein inhibitor. L-GO-203 TFA is an anti-cancer peptide for targeting intracellular proteins ^[1].

HY-P5274

BACE1 (485-501)	Peptides	Others
BACE1 (485-501) is the carboxyl terminal of BACE1 (Beta-site APP cleaving enzyme 1). BACE1 (485-501) can be used as antigen to produce anti-BACE1-C antibody ^[1].

HY-P10161

Ac-DMQD-pNA	Peptides	Others
Ac-DMQD-pNA is a peptide substrate. Both of the recombinant CgCaspase-1 (rCgCaspase-1) and the C-terminus of CgCaspase-1 (rCgCaspase-1-C) exhibits similar caspase activity towards proteolytic substrate Ac-DMQD-pNA and Ac-DEVD-pNA (HY-P1006) ^[1] .

HY-P5530

2Abz-SVARTLLV-Lys(Dnp)-NH2

Peptides Others

2Abz-SVARTLLV-Lys(Dnp)-NH2 is a biological active peptide. (C1-inhibitor P4-P4′ substrate)

HY-P3103

PINT-87aa	DNA/RNA Synthesis	Cancer
PINT-87aa, an 87-amino acid (aa) peptide, is encoded by the circular form of the long intergenic non-protein-coding RNA p53-induced transcript (LINC-PINT). PINT-87aa directly interacts with polymerase associated factor complex (PAF1c) and inhibits the transcriptional elongation of multiple oncogenes. PINT-87aa suppresses glioblastoma cell proliferation in vitro and in vivo ^[1].

HY-P3103A

PINT-87aa TFA	DNA/RNA Synthesis	Cancer
PINT-87aa TFA, an 87-amino acid (aa) peptide, is encoded by the circular form of the long intergenic non-protein-coding RNA p53-induced transcript (LINC-PINT). PINT-87aa TFA directly interacts with polymerase associated factor complex (PAF1c) and inhibits the transcriptional elongation of multiple oncogenes. PINT-87aa TFA suppresses glioblastoma cell proliferation in vitro and in vivo ^[1].

HY-108795A

Albiglutide fragment TFA GLP-1-Gly8 TFA; GLP-1 (7-36) analog TFA	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) TFA is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment TFA significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-P1345

TLQP-21	Complement System	Neurological Disease Endocrinology
TLQP-21, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor 1 (C3aR1) agonist (EC₅₀: mouse TLQP-21=10.3 μM; human TLQP-21=68.8 μM). TLQP-21 activates C3aR1 to induce an increase of intracellular Ca ²⁺. TLQP-21 is used for the research in regulation of nociception and other relevant physiologic functions ^[1] .

HY-108795

Albiglutide fragment GLP-1-Gly8; GLP-1 (7-36) analog	GLP Receptor	Metabolic Disease
Albiglutide fragment (GLP-1 (7-36) analog) is an active fragment of Albiglutide (7-36) and a glucagon-like peptide-1 (GLP-1) analog (a long-acting *GLP-1* receptor agonist). Albiglutide is produced by the fusion of DPP-4 resistant GLP-1 dimer with the human albumin gene. Moreover, Albiglutide fragment significantly reduces glycosylated hemoglobin (A1C) and is used in type 2 diabetes (T2D) studies ^[1] .

HY-P1345A

TLQP-21 TFA 1 Publications Verification	Complement System	Neurological Disease Endocrinology
TLQP-21 TFA, a VGF-derived peptide endowed of endocrine and extraendocrine properties, is a potent G-protein-coupled receptor complement-3a receptor1 (C3aR1) agonist (EC₅₀: mouse TLQP-21=10.3 μM; human TLQP-21=68.8μM). TLQP-21 TFA activates C3aR1 to induce an increase of intracellular Ca ²⁺. TLQP-21 TFA is used for the research in regulation of nociception and other relevant physiologic functions ^[1] .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0376

Liquiritin 5 Publications Verification	Structural Classification Neurological Disease Classification of Application Fields Source classification Plants Monophenols Flavonoids Leguminosae Flavonones Phenols Inflammation/Immunology Disease Research Fields Glycyrrhiza uralensis Fisch.	Reactive Oxygen Species
Liquiritin, a flavonoid isolated from Glycyrrhiza uralensis, is a potent and competitive *AKR1C1* inhibitor with IC₅₀s of 0.62 μM, 0.61 μM, and 3.72μM for AKR1C1, AKR1C2 and AKR1C3, respectively. Liquiritin efficiently inhibits progesterone metabolism mediated by AKR1C1 in vivo ^[1]. Liquiritin acts as an antioxidant and has neuroprotective, anti-cancer and anti-inflammatory activity .

HY-N10361

Drupanin	Monophenols Classification of Application Fields Animals Source classification Phenols Disease Research Fields Cancer	Others
Drupanin is a compound isolated from green propolis. Drupanin can selectively inhibit the AKR1C3 enzyme. Drupanin has the potential for the research of breast cancer ^[1].

HY-N10344

Glucoarabin	Structural Classification Natural Products Classification of Application Fields Source classification Camelina sativa (L.) Crantz Glucosinolates Plants Brassicaceae Disease Research Fields Cancer	Others
Glucoarabin is a bioactive glucosinolate. In Hepa1c1c7 cells, hydrolyzed Glucoarabin (hGSL 9) upregulates the phase II detoxification enzyme quinone reductase (NQO1), with no effect on cytochrome P450 (CYP) 1A1 activity ^[1].

HY-N6802

Tigloylgomisin H	Structural Classification Classification of Application Fields Source classification Lignans Phenylpropanoids Plants Schisandraceae Disease Research Fields Schisandra chinensis (Turcz.) Baill. Cancer	Others
Tigloylgomisin H is a lignan isolated from the fruits of S. chinensis, can induce quinone reductase (QR) activity in Hepa1c1c7 mouse hepatocarcinoma cells. Tigloylgomisin H functions as a monofunctional inducer that specifically upregulates phase II detoxification enzyme NQO1 through the NF-E2-related factor 2 (Nrf2)-ARE pathway, thus represents a potential liver cancer prevention agent ^[1].

Species:	Human (75) Virus (2) Rhesus Macaque (5) Mouse (17) Rat (3) Cynomolgus (3) Pig (1)
Tag:	His (75) SUMO (6) Tag Free (13) Avi (5) Myc (2) GST (8) Fc (15) Flag (1)
Source:	HEK293 (48) E. coli Cell-free (3) CHO (1) P. pastoris (4) Sf9 insect cells (10) E. coli (40)

Cat. No.	Compare	Product Name	Species	Source

HY-P77813

	NKp30/NCR3 Protein, Human (Biotinylated, HEK293, His-Avi) CD337; LY117; NCR3; NKp30; 1c7; MALS	Human	HEK293
	NKp30/NCR3 protein is a cell membrane receptor on NK cells and is activated by binding to ligands such as BAG6 and NCR3LG1. This activation enhances NK cell cytotoxicity against neighboring cells that produce these ligands, including tumor cells. NKp30/NCR3 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived NKp30/NCR3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of NKp30/NCR3 Protein, Human (Biotinylated, HEK293, His-Avi) is 120 a.a., with molecular weight of ~20 kDa.

HY-P77811

	NKp30/NCR3 Protein, Human (120a.a, HEK293, Fc) CD337; LY117; NCR3; NKp30; 1c7; MALS	Human	HEK293
	NKp30/NCR3 protein is a cell membrane receptor on NK cells and is activated by binding to ligands such as BAG6 and NCR3LG1. This activation enhances NK cell cytotoxicity against neighboring cells that produce these ligands, including tumor cells. NKp30/NCR3 Protein, Human (120a.a, HEK293, Fc) is the recombinant human-derived NKp30/NCR3 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of NKp30/NCR3 Protein, Human (120a.a, HEK293, Fc) is 120 a.a., with molecular weight of 53-60 kDa.

HY-P77812

	NKp30/NCR3 Protein, Human (HEK293, His-Avi) CD337; LY117; NCR3; NKp30; 1c7; MALS	Human	HEK293
	NKp30/NCR3 protein is a cell membrane receptor on NK cells and is activated by binding to ligands such as BAG6 and NCR3LG1. This activation enhances NK cell cytotoxicity against neighboring cells that produce these ligands, including tumor cells. NKp30/NCR3 Protein, Human (HEK293, His-Avi) is the recombinant human-derived NKp30/NCR3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of NKp30/NCR3 Protein, Human (HEK293, His-Avi) is 120 a.a., with molecular weight of 26-40 kDa.

HY-P77452

	NKp30/NCR3 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) NCR3 Protein; Natural Cytotoxicity Triggering Receptor 3; NCR3; CD337; 1c7; LY117	Rhesus Macaque	HEK293
	NKp30/NCR3 protein is a cell membrane receptor on natural killer (NK) cells that activates cytotoxicity by binding to ligands such as BAG6 and NCR3LG1, stimulating NK cells to respond against neighboring cells (including tumor cells) expressing these ligands. NKp30/NCR3 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived NKp30/NCR3 protein, expressed by HEK293 , with C-His labeled tag. The total length of NKp30/NCR3 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) is 117 a.a., with molecular weight of ~23-32 kDa.

HY-P72506

	NKp30/NCR3 Protein, Human (120a.a, HEK293, His) NCR3 Protein; Natural Cytotoxicity Triggering Receptor 3; NCR3; CD337; 1c7; LY117	Human	HEK293
	NKp30/NCR3 protein is a cell membrane receptor on NK cells and is activated by binding to ligands such as BAG6 and NCR3LG1. This activation enhances NK cell cytotoxicity against neighboring cells that produce these ligands, including tumor cells. NKp30/NCR3 Protein, Human (120a.a, HEK293, His) is the recombinant human-derived NKp30/NCR3 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of NKp30/NCR3 Protein, Human (120a.a, HEK293, His) is 120 a.a., with molecular weight of 20-31 kDa.

HY-P701935

	ADH1C Protein, Human ADH1c; Alcohol dehydrogenase 1c; Alcohol dehydrogenase subunit gamma	Human	E. coli
	ADH1C Proteinas, an alcohol dehydrogenase, plays a pivotal role in ethanol catabolism, exhibiting heightened activity in ethanol oxidation. ADH1C Protein, Human is the recombinant human-derived ADH1C protein, expressed by E. coli , with tag free. The total length of ADH1C Protein, Human is 374 a.a., .

HY-P71802

	Carboxylesterase 1C Protein, Mouse (P.pastoris, His) Carboxylesterase 1c; Ces N; Ces1c; Ee 1; Ee 4; Ee1; Es N; Es1; Es4; EsN; EST1c_MOUSE; Esterase 1; Liver carboxylesterase N; Lung surfactant convertase; PES-N; PESN	Mouse	P. pastoris
	The carboxylesterase 1C protein is essential for xenobiotic detoxification and ester/amide prodrug activation, as well as participating in extracellular metabolism. Its multifunctional effects include processing of pulmonary surfactant. Carboxylesterase 1C Protein, Mouse (P.pastoris, His) is the recombinant mouse-derived Carboxylesterase 1C protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of Carboxylesterase 1C Protein, Mouse (P.pastoris, His) is 532 a.a., with molecular weight of ~60.6 kDa.

HY-P71548

	JMJD1C Protein, Human (His-SUMO-Myc) Jmjd1c; Jumonji domain containing 1c ; Jumonji domain-containing protein 1c; Probable JmjC domain-containing histone demethylation protein 2C; Thryoid receptor interacting protein; Thyroid receptor-interacting protein 8; TR-interacting protein 8; TRIP-8; TRIP8	Human	E. coli
	The JMJD1C protein is a possible histone demethylase that centrally affects the histone code by targeting “Lys-9” of histone H3. Its enzymatic activity produces formaldehyde and succinic acid. JMJD1C Protein, Human (His-SUMO-Myc) is the recombinant human-derived JMJD1C protein, expressed by E. coli , with C-Myc, N-SUMO, N-10*His labeled tag. The total length of JMJD1C Protein, Human (His-SUMO-Myc) is 225 a.a., with molecular weight of ~45.5 kDa.

HY-P72093

	ASPN Protein, Human (His-SUMO) ASPN; ASPN protein; ASPN_HUMAN; Asporin LRR class 1; ; Asporin; Asporin proteoglycan; FLJ20129; LRR class 1; Periodontal ligament associated protein 1; Periodontal ligament-associated protein 1; PLAP 1; PLAP-1; PLAP1; SLRR 1c; SLRR1c; Small leucine rich protein 1c	Human	E. coli
	ASPN protein acts as a negative regulator in periodontal ligament (PDL) differentiation and mineralization, preventing ossification and maintaining homeostasis of the tooth support system. It inhibits BMP2-induced cell differentiation by blocking the binding of BMP2 to BMPR1B, thereby preventing BMP-dependent activation of SMAD proteins. ASPN Protein, Human (His-SUMO) is the recombinant human-derived ASPN protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag. The total length of ASPN Protein, Human (His-SUMO) is 348 a.a., with molecular weight of ~60 kDa.

HY-P71228

	PPP1CC Protein, Human (His) Serine/Threonine-Protein Phosphatase PP1-Gamma Catalytic Subunit; PP-1G; Protein Phosphatase 1c Catalytic Subunit; PPP1cC	Human	E. coli
	PPP1CC protein is a multifunctional phosphatase that forms a specific holoenzyme with more than 200 regulatory proteins to dephosphorylate various biological targets. PPP1CC is critical for cell division and regulates glycogen metabolism, muscle contractility, and protein synthesis. PPP1CC Protein, Human (His) is the recombinant human-derived PPP1CC protein, expressed by E. coli , with N-6His, C-6His labeled tag. The total length of PPP1CC Protein, Human (His) is 323 a.a., with molecular weight of 30-40 kDa.

HY-P71141

	SHP-1 Protein, Human (His) Tyrosine-Protein Phosphatase Non-Receptor Type 6; Hematopoietic Cell Protein-Tyrosine Phosphatase; Protein-Tyrosine Phosphatase 1c; PTP-1c; Protein-Tyrosine Phosphatase SHP-1; SH-PTP1; PTPN6; HCP; PTP1c	Human	E. coli
	SHP-1 Protein modulates signaling from tyrosine-phosphorylated cell surface receptors, including KIT and EGFR. It enhances the inhibition of mast cell activation via the Lilrb4a receptor. The SH2 regions interact with cellular components to regulate its phosphatase activity. In collaboration with MTUS1, it induces UBE2V2 expression upon angiotensin II stimulation. SHP-1 plays a crucial role in hematopoiesis. SHP-1 Protein, Human (His) is the recombinant human-derived SHP-1 protein, expressed by E. coli , with C-6*His labeled tag. The total length of SHP-1 Protein, Human (His) is 299 a.a., with molecular weight of ~33.0 kDa.

HY-P71022

	PP1MG Protein, Human (His) Protein Phosphatase 1G; Protein Phosphatase 1c; Protein Phosphatase 2C Isoform Gamma; PP2C-Gamma; Protein Phosphatase Magnesium-Dependent 1 Gamma; PPM1G; PPM1c	Human	E. coli
	PP1MG Protein, a member of PPM family of serine/threonine phosphatases, has an important role in controlling cell cycle progression. PP1MG Proteinregulates the phosphorylation of SRSF3 in hepatocellular carcinoma (HCC) and contributes to the proliferation, invasion, and metastasis of HCC. PP1MG Protein forms a distinct holoenzyme complex with the PP2A regulatory subunit B56δ. B56δ‐PPM1G dephosphorylates α‐catenin at serine 641, which is necessary for the appropriate assembly of adherens junctions and the prevention of aberrant cell migration. PP1MG Protein, Human (His) is the recombinant human-derived PP1MG protein, expressed by E. coli , with C-6*His labeled tag. The total length of PP1MG Protein, Human (His) is 230 a.a., with molecular weight of ~30.0 kDa.

HY-P71012

	SULT1C2 Protein, Human (His) Sulfotransferase 1c2; ST1c2; Sulfotransferase 1c1; SULT1c#1; humSULTC2; SULT1c2; SULT1c1;	Human	E. coli
	The SULT1C2 protein utilizes PAPS to catalyze sulfate conjugation and has specific affinity for sulfonated p-nitrophenol. It selectively avoids sulfonated steroids, dopamine, acetaminophen or alpha-naphthol. SULT1C2 Protein, Human (His) is the recombinant human-derived SULT1C2 protein, expressed by E. coli , with N-6*His labeled tag. The total length of SULT1C2 Protein, Human (His) is 296 a.a., with molecular weight of ~38.0 kDa.

HY-P7470

	AKR1C4 Protein, Human (His) rHuAldo-keto Reductase 1c4, His; AKR-1c4; Aldo-keto Reductase 1c4	Human	E. coli
	AKR1C4 Protein, Human (His) is a human recombinant AKR1C4 with a N-Terminal His-tag. AKR1C4 Protein, Human (His) is derived from E. coli and corresponding to the amino acids 1-323 of human Aldo-keto Reductase 1C4/AKR1C4.

HY-P71342

	SULT1C4 Protein, Human (His) SULT1c4; Sulfotransferase; SULT1c2; hCG_27301; ;	Human	E. coli
	The SULT1C4 protein is an important member of the sulfotransferase 1 family and plays a crucial role in phase II drug metabolism and binding of endogenous compounds. Its research enhances the understanding of xenobiotic metabolism and has potential applications in pharmacology. SULT1C4 Protein, Human (His) is the recombinant human-derived SULT1C4 protein, expressed by E. coli , with N-6*His labeled tag. The total length of SULT1C4 Protein, Human (His) is 102 a.a., with molecular weight of ~14.0 kDa.

HY-P74648

PDE1C Protein, Human (sf9, His-GST)

Phosphodiesterase; PDE1c
Human Sf9 insect cells

HY-P75520

	AKR1C2 Protein, Human (His) AKR-1c2; Aldo-keto reductase family 1 member C2; DD-2; AKR1c2	Human	E. coli
	AKR1C2 protein: Cytoplasmic aldehyde-keto reductase, which uses NADH and NADPH to reduce ketosteroids to hydroxysteroids. AKR1C2 Protein, Human (His) is the recombinant human-derived AKR1C2 protein, expressed by E. coli , with N-6*His labeled tag. The total length of AKR1C2 Protein, Human (His) is 323 a.a., with molecular weight of ~38 kDa.

HY-P7604

	AKR1C3 Protein, Human (HEK293, His) rHuAKR1c3, His; AKR1c3; HA1753; Dihydrodiol Dehydrogenase Type I; Indanol Dehydrogenase; Prostaglandin F Synthase	Human	HEK293
	AKR1C3 Protein, Human (HEK293, His) expresses in HEK293 cells with a His tag. Aldo-keto reductase family 1 member C3 (AKR1C3) is a steroidogenic enzyme that plays a crucial role in the conversion of adrenal androgen dehydroepiandrosterone (DHEA) into high-affinity ligands for the androgen receptor (testosterone [T] and dihydrotestosterone [DHT]).

HY-P76210

	CD1C-B2M Heterodimer Protein, Rhesus Macaque (HEK293, His) T-cell surface glycoprotein CD1c; CD1c; Beta-2-microglobulin; B2M	Rhesus Macaque	HEK293
	CD1C belongs to Group 1 of the transmembrane glycoprotein CD1 family. CD1C protein, as a key antigen-presenting molecule, has shown the ability to bind both self and non-self lipid and glycolipid antigens, mediating host defense against tuberculosis. CD1C is associated with breast cancer prognosis and immune invasion. CD1C-B2M Heterodimer Protein, Rhesus Macaque (HEK293, His) is a recombinant protein dimer complex containing Rhesus Macaque-derived CD1C-B2M Heterodimer protein, expressed by HEK293 , with C-His labeled tag. CD1C-B2M Heterodimer Protein, Rhesus Macaque (HEK293, His), has molecular weight of ~44.7 (33.1+ 11.6) KDa.

HY-P7692

	HABP1/C1QBP Protein, Human (His) rHuHABP1/C1QBP, His; Complement component 1 Q subcomponent-binding protein, mitochondrial; HABP1	Human	E. coli
	HABP1/C1QBP Protein, Human (His) is a recombinant human HABP1 (hyaluronan-binding protein 1)/C1QBP (complement component 1, q subcomponent binding protein) produced in HEK293 cells, with His tag. HABP1/C1QBP is a ubiquitously present glycoprotein having specific affinity towards hyaluronan (HA).

HY-P700398

	C5AR1 Protein-VLP, Human (HEK293, His) complement component 5a receptor 1; C5R1, complement component 5 receptor 1 (C5a ligand); C5a anaphylatoxin chemotactic receptor; C5A; C5AR; CD88; C5a-R; C5a ligand; C5a anaphylatoxin receptor; complement component 5 receptor 1; C5R1	Human	HEK293
	C5AR1 Protein-VLP, Human (HEK293, His) is recommended for animal immunization, ELISA. It is not recommended for receptor-ligand interaction detection and SPR/BLI assay since there are other irrelevant membrane proteins of the host on the VLP envelope, and the receptor-ligand interaction will have strong background interference. High requirements for chips and experimental protocols are needed for SPR/BLI assays.

HY-P7469

	AKR1C2 Protein, Human rHuAldo-keto reductase family 1 member C2; AKR-1c2; Aldo-keto reductase family 1 member C2	Human	E. coli
	AKR1C2 Protein, Human is a recombinant human AKR1C2. AKR1C2 is a member of the aldo/keto reductase superfamily and has critical roles in the tumorigenesis and progression of malignant tumours.

HY-P74221

	C-Reactive Protein, Human (HEK293) C-Reactive Protein; CRP; PTX1	Human	HEK293
	C-Reactive Protein, an acute-phase protein, is a marker of inflammation and is produced by the liver. It is used as a diagnostic tool to assess the presence and severity of inflammation in various diseases. C-Reactive Protein's role in inflammation detection and its clinical significance in disease management make it a subject of interest in medical research. C-Reactive Protein, Human (HEK293) is the recombinant human-derived C-Reactive protein, expressed by HEK293 , with tag free. The total length of C-Reactive Protein, Human (HEK293) is 206 a.a., with molecular weight of ~26 kDa.

HY-P701806

	MARK1 Protein, Human MARK1; Serine/threonine-protein kinase MARK1; MAP/microtubule affinity-regulating kinase 1; PAR1 homolog c; Par-1c; Par1c	Human	E. coli
	MARK1 is an important serine/threonine protein kinase that critically regulates cell polarity and microtubule dynamics. It phosphorylates microtubule-associated proteins (DCX, MAP2, MAP4, MAPT/TAU), causing their dissociation and disassembly. MARK1 Protein, Human is the recombinant human-derived MARK1 protein, expressed by E. coli , with tag free. The total length of MARK1 Protein, Human is 751 a.a., .

HY-P74219

	C-Reactive Protein, Rat (HEK293, His) C-Reactive Protein; CRP; PTX1	Rat	HEK293
	Reactive protein (CRP) performs multiple functions of host defense, including promoting agglutination, bacterial capsule swelling, phagocytosis, and complement fixation. These activities are promoted by its calcium-dependent binding to phosphocholine, suggesting its role in orchestrating immune responses against pathogens. C-Reactive Protein, Rat (HEK293, His) is the recombinant rat-derived C-Reactive protein, expressed by HEK293 , with C-His labeled tag. The total length of C-Reactive Protein, Rat (HEK293, His) is 211 a.a., with molecular weight of ~30 kDa.

HY-P77514

	C-Reactive Protein, Human (Biotinylated, HEK293) C-Reactive Protein; CRP; PTX1	Human	HEK293
	C-Reactive Protein, an acute-phase protein, is a marker of inflammation and is produced by the liver. It is used as a diagnostic tool to assess the presence and severity of inflammation in various diseases. C-Reactive Protein's role in inflammation detection and its clinical significance in disease management make it a subject of interest in medical research. C-Reactive Protein, Human (Biotinylated, HEK293) is the recombinant human-derived C-Reactive protein, expressed by HEK293 , with tag free. The total length of C-Reactive Protein, Human (Biotinylated, HEK293) is 224 a.a., with molecular weight of ~23 KDa.

HY-P701807

	MARK1 Protein, Human (His) MARK1; Serine/threonine-protein kinase MARK1; MAP/microtubule affinity-regulating kinase 1; PAR1 homolog c; Par-1c; Par1c	Human	E. coli
	MARK1 is an important serine/threonine protein kinase that critically regulates cell polarity and microtubule dynamics. It phosphorylates microtubule-associated proteins (DCX, MAP2, MAP4, MAPT/TAU), causing their dissociation and disassembly. MARK1 Protein, Human (His) is the recombinant human-derived MARK1 protein, expressed by E. coli , with N-6*His labeled tag. The total length of MARK1 Protein, Human (His) is 751 a.a., .

HY-P71301

	Serpin A1c Protein, Mouse (HEK293, His) Alpha-1-antitrypsin 1-3; Alpha-1 protease inhibitor 3; Alpha-1 protease inhibitor 6; Alpha-1-antitrypsin 1-6; Serine protease inhibitor 1-3; Serine protease inhibitor 1-6; Serine protease inhibitor A1c; Serpin A1c; Serpina1c; Dom3; Dom6; Spi1-3; Spi1-6	Mouse	HEK293
	The Serpin A1c protein is a skilled guardian of cellular regulation, specifically acting as an inhibitor of serine proteases, specifically trypsin and chymotrypsin. Its efficacy in blocking enzymatic activity contrasts with its relative ineffectiveness against elastase. Serpin A1c Protein, Mouse (HEK293, His) is the recombinant mouse-derived Serpin A1c protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Serpin A1c Protein, Mouse (HEK293, His) is 389 a.a., with molecular weight of 45-60 kDa.

HY-P77747

MCEMP1 Protein, Mouse (HEK293, Fc)

MCEMP1; C19orf59; MGC132456
Mouse HEK293

HY-P7693

	C1QTNF1/CTRP1 Protein, Human (HEK293, His) rHuC1QTNF1/CTRP1, His; Complement C1q Tumor Necrosis Factor-Related Protein 1; C1QTNF1; CTRP1	Human	HEK293
	C1QTNF1/CTRP1 Protein, Human (HEK293, His) is a recombinant human C1q/TNF-related protein 1 (CTRP1) produced in HEK293 cells, with His tag. CTRP1 is an adipokine that is mainly expressed in adipose-derived cells and adipocytes.

HY-P7874

	C-Reactive Protein, Human (His) rHuC-reactive protein/CRP, His; C-Reactive Protein; CRP; PTX1	Human	E. coli
	C-Reactive Protein, an acute-phase protein, is a marker of inflammation and is produced by the liver. It is used as a diagnostic tool to assess the presence and severity of inflammation in various diseases. C-Reactive Protein's role in inflammation detection and its clinical significance in disease management make it a subject of interest in medical research. C-Reactive Protein, Human (His) is the recombinant human-derived C-Reactive protein, expressed by E. coli , with C-6*His labeled tag. The total length of C-Reactive Protein, Human (His) is 206 a.a., with molecular weight of ~27.0 kDa.

HY-P74220

	C-Reactive Protein, Mouse (225a.a, HEK293, His) C-Reactive Protein; CRP; PTX1	Mouse	HEK293
	C-reactive protein (CRP) has cholesterol-binding, complement C1q complex-binding, and low-density lipoprotein particle-binding activities, and plays a role in complement activation, gene expression regulation, and superoxide anion generation. It is located in filopodia and growth cones and is expressed in embryos and liver. C-Reactive Protein, Mouse (225a.a, HEK293, His) is the recombinant mouse-derived C-Reactive protein, expressed by HEK293 , with C-His labeled tag. The total length of C-Reactive Protein, Mouse (225a.a, HEK293, His) is 206 a.a., with molecular weight of 25-30 kDa.

HY-P77584

	CYTL1 Protein, Mouse (HEK293, Fc) Protein C17; CYTL1; C4orf4	Mouse	HEK293
	CYTL1 is a cytokine-like protein specifically expressed in bone marrow and cord blood mononuclear cells that bear the CD34 surface marker. CYTL1 exhibits specific expression in CD34+ hematopoietic cells, indicating its selective presence within this subset of cells involved in the regulation of hematopoiesis. CYTL1 regulates chondrogenesis and is required for the maintenance of cartilage homeostasis and, in addition, may act as a regulator of embryo implantation in early pregnancy. CYTL1 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived CYTL1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CYTL1 Protein, Mouse (HEK293, Fc) is 114 a.a., with molecular weight of 48-52 kDa.

HY-P73700

	PRAC Protein, Human (His-SUMO) Small nuclear protein PRAC1; PRAC1; C17orf92; PRAC	Human	E. coli
	PRAC Protein exhibits high expression in the prostate, rectum, and distal colon, with weaker expression in the bladder. Its prominence in prostate cancer cell lines suggests a potential link to prostate cancer pathology. The tissue-specific expression emphasizes PRAC Protein's potential roles in normal physiological processes and cancer contexts. PRAC Protein, Human (His-SUMO) is the recombinant human-derived PRAC protein, expressed by E. coli , with N-His, N-SUMO labeled tag. The total length of PRAC Protein, Human (His-SUMO) is 57 a.a., with molecular weight of ~25 kDa.

HY-P702228

	CACNA1C Protein, Pig (Cell-Free, His) Voltage-dependent L-type calcium channel subunit alpha-1c; Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle; Voltage-gated calcium channel subunit alpha Cav1.2	Pig	E. coli Cell-free
	The CACNA1C protein is the alpha-1C subunit of voltage-gated calcium channels that generate L-type calcium currents that are critical for calcium influx and sarcoplasmic release. Its role in excitation-contraction coupling is critical for cardiac development, rhythm regulation, and smooth muscle cell contraction. CACNA1C Protein, Pig (Cell-Free, His) is the recombinant pig-derived CACNA1C protein, expressed by E. coli Cell-free , with N-10*His labeled tag. The total length of CACNA1C Protein, Pig (Cell-Free, His) is 169 a.a., with molecular weight of 22.3 kDa.

HY-P7199

	I-309/CCL1 Protein, Human rHuI-309/CCL1; C-C motif chemokine 1; SCYA1	Human	E. coli
	I-309/CCL1 Protein, Human is a cytokine that mediates inflammatory immune responses, viral infections, and tumorigenesis by interacting with the CCR8 chemokine receptor on the cell surface and attracting monocytes, natural killer cells, and immature B-cell nuclear dendritic cells. I-309/CCL1 Protein, Human is a recombinant human CCL1(S23-K96) expressed by E. coli.

HY-P70965

	Otolin-1 Protein, Human (HEK293, His) OTOL1; otolin 1; Otolin-1; C1qTNF15	Human	HEK293
	Otolin-1 is a collagen-like protein that shows specific expression in the inner ear, where it is a key component that provides the organic scaffolding for the otic bulb (the calcium carbonate structure found in the otic bulb and utricle). Otolin-1 plays a key role as a scaffold in the biomineralization process by chelating calcium and forming interconnected fibrils between otoliths, thereby integrating into the calcium crystal structure. Otolin-1 Protein, Human (HEK293, His) is the recombinant human-derived Otolin-1 protein, expressed by HEK293 , with C-6*His labeled tag. The total length of Otolin-1 Protein, Human (HEK293, His) is 454 a.a., with molecular weight of 84-94 kDa.

HY-P74502

	TPM1 Protein, Human (His) Tropomyosin alpha-1 chain; Tropomyosin-1; TPM1; C15orf13; TMSA	Human	E. coli
	TPM1 encodes tropomyosin, a key actin-binding component in muscle contraction and cytoskeletal structure. It contains α-helical chains that form a coiled-coil structure that stabilizes actin filaments. TPM1 Protein, Human (His) is the recombinant human-derived TPM1 protein, expressed by E. coli , with N-His labeled tag. The total length of TPM1 Protein, Human (His) is 284 a.a., with molecular weight of ~35 kDa.

HY-P76966

	USH1C Protein, Human (His) Harmonin; Antigen NY-CO-38/NY-CO-37; Protein PDZ-73; AIE75	Human	E. coli
	USH1C, an anchoring and scaffolding protein, is crucial for cochlear hair cell mechanotransduction. It forms a network with USH1G, CDH23, and MYO7A, contributing to the development and maintenance of hair cell bundles. As part of the intermicrovillar adhesion complex (IMAC), USH1C regulates brush border differentiation, influencing microvilli organization and length. It recruits CDHR2, CDHR5, and MYO7B to microvilli tips, participating in complexes like IMAC, USH1C/USH1G/MYO7A, and interacting with various proteins, highlighting its multifaceted role. USH1C Protein, Human (His) is the recombinant human-derived USH1C protein, expressed by E. coli, with N-6*His labeled tag. The total length of USH1C Protein, Human (His) is 552 a.a., with molecular weight of ~70 kDa.

HY-P77080

MCEMP1 Protein, Human (HEK293, Fc)

Mast cell-expressed membrane protein 1; C19orf59
Human HEK293

HY-P77583

	CYTL1 Protein, Human (114a.a, HEK293, Fc) Protein C17; CYTL1; C4orf4	Human	HEK293
	CYTL1 protein is specifically expressed in CD34+ hematopoietic cells, indicating that it exists selectively in this hematopoietic cell subpopulation. This targeted expression pattern suggests a potential role in maintaining or differentiating CD34+ cells, emphasizing the importance of CYTL1 in the complex molecular processes that control blood cell development. CYTL1 Protein, Human (114a.a, HEK293, Fc) is the recombinant human-derived CYTL1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CYTL1 Protein, Human (114a.a, HEK293, Fc) is 114 a.a., with molecular weight of 50-55 kDa.

HY-P7198

	I-309/CCL1 Protein, Human (CHO) rHuI-309/CCL1; C-C motif chemokine 1; SCYA1	Human	CHO
	I-309/CCL1 Protein, Human (CHO) is a cytokine that mediates inflammatory immune responses, viral infections, and tumorigenesis by interacting with the CCR8 chemokine receptor on the cell surface and attracting monocytes, natural killer cells, and immature B-cell nuclear dendritic cells. I-309/CCL1 Protein, Human (CHO) is a recombinant human CCL1 (K24-K96) expressed by CHO.

HY-P76185

	HABP1/C1QBP Protein, Mouse (His) Complement component 1 Q subcomponent-binding protein, mitochondrial; HABP1	Mouse	E. coli
	HABP1/C1QBP Protein, part of the MAM33 family, is associated with a distinct protein family known for unique characteristics and functions. In the MAM33 family, HABP1 likely plays a significant role in associated cellular processes, though specific functions need exploration. Investigating HABP1's functions and implications within the broader MAM33 family will enhance understanding of its unique properties and potential roles in cellular processes, offering insights into its significance within this protein family. HABP1/C1QBP Protein, Mouse (His) is the recombinant mouse-derived HABP1/C1QBP protein, expressed by E. coli, with N-His labeled tag. The total length of HABP1/C1QBP Protein, Mouse (His) is 208 a.a., with molecular weight of ~32 KDa.

HY-P702572

	PPAR gamma Protein, Human (P.pastoris, His) CIMT1, GLM1, NR1c31, PPARG2, PPARG5, PPARgamma, PPARG	Human	P. pastoris
	The PPAR gamma protein is a nuclear receptor that binds to peroxisome proliferators and is activated upon ligand binding to specific PPREs on DNA. It regulates target gene transcription and controls fatty acid metabolism. PPAR gamma Protein, Human (P.pastoris, His) is the recombinant human-derived PPAR gamma protein, expressed by P. pastoris , with N-6*His labeled tag. The total length of PPAR gamma Protein, Human (P.pastoris, His) is 477 a.a., with molecular weight of 56-60 kDa.

HY-P73701

	PPAR gamma Protein, Human (sf9, His-GST) CIMT1; GLM1; NR1c31; PPARG2; PPARG5; PPARgamma; PPARG	Human	Sf9 insect cells
	The PPAR gamma protein is a nuclear receptor that binds to peroxisome proliferators and is activated upon ligand binding to specific PPREs on DNA. It regulates target gene transcription and controls fatty acid metabolism. PPAR gamma Protein, Human (sf9, His-GST) is the recombinant human-derived PPAR gamma protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag. The total length of PPAR gamma Protein, Human (sf9, His-GST) is 505 a.a., with molecular weight of ~85.4 kDa.

HY-P75926

	METTL1 Protein, Human (His) tRNA (guanine-N(7)-)-methyltransferase; Methyltransferase-like protein 1; METTL1; C12orf1	Human	E. coli
	METTL1, the catalytic component of the METTL1-WDR4 methyltransferase complex, is instrumental in mediating the formation of N(7)-methylguanine in various RNA species, including tRNAs, mRNAs, and microRNAs (miRNAs). Specifically, METTL1 catalyzes the addition of N(7)-methylguanine at position 46 (m7G46) within a significant subset of tRNAs containing the 5'-RAGGU-3' motif in the variable loop. This modification, such as m7G46, stabilizes tRNA tertiary structure and shields tRNAs from decay. METTL1 also serves as a methyltransferase for internal N(7)-methylguanine in mRNAs, particularly in response to stress, leading to the relocalization of methylated mRNAs to stress granules and consequent translational suppression. Furthermore, METTL1 methylates specific miRNAs, including let-7, facilitating let-7 miRNA processing by disrupting inhibitory secondary structures within primary miRNA transcripts. Beyond its role in RNA modification, METTL1 emerges as a regulator of embryonic stem cell self-renewal and differentiation. METTL1 Protein, Human (His) is the recombinant human-derived METTL1 protein, expressed by E. coli , with N-His labeled tag. The total length of METTL1 Protein, Human (His) is 234 a.a., with molecular weight of ~30 kDa.

HY-P76537

	PDRG1 Protein, Human (His) p53 and DNA damage-regulated protein 1; PDRG1; C20orf126; PDRG	Human	E. coli
	As a component of the PAQosome complex, the PDRG1 protein may play a role in chaperone-mediated protein folding. PAQosome is composed of multiple protein complexes, including PDRG1, and coordinates the biogenesis of multiple protein complexes. PDRG1 Protein, Human (His) is the recombinant human-derived PDRG1 protein, expressed by E. coli , with N-His labeled tag. The total length of PDRG1 Protein, Human (His) is 133 a.a., with molecular weight of ~12 kDa.

HY-P7632

	B7-1/CD80 Protein, Mouse (208a.a, HEK293, Fc) rMuB7-1, C-Fc; Activation B7-1 antigen	Mouse	HEK293
	B7-1/CD80 Protein, Mouse (HEK293, Fc) is not only expressed on APCs, but also is expressed on T cells. B7-1:PD-L1 interaction can inhibit T cell proliferation and cytokine production.

HY-P75574

	Allergin-1 Protein, Human (HEK293, Fc) Allergy inhibitory receptor 1; MCA-32; MILR1; C17orf60; MCA32	Human	HEK293
	Allergin-1 Protein, an immunoglobulin-like receptor, crucially acts as a negative regulator in mast cells, inhibiting degranulation. Operating as a monomer, it interacts with signaling molecules like tyrosine-phosphorylated PTPN6, PTPN11, and INPP5D, forming complexes that suppress IgE-mediated mast cell activation, thus dampening type I immediate hypersensitivity reactions. Allergin-1 Protein, Human (HEK293, Fc) is the recombinant human-derived Allergin-1 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Allergin-1 Protein, Human (HEK293, Fc) is 227 a.a., with molecular weight of ~50.1 kDa.

HY-P75575

	Allergin-1 Protein, Human (HEK293, His) Allergy inhibitory receptor 1; MCA-32; MILR1; C17orf60; MCA32	Human	HEK293
	Allergin-1 Protein, an immunoglobulin-like receptor, crucially acts as a negative regulator in mast cells, inhibiting degranulation. Operating as a monomer, it interacts with signaling molecules like tyrosine-phosphorylated PTPN6, PTPN11, and INPP5D, forming complexes that suppress IgE-mediated mast cell activation, thus dampening type I immediate hypersensitivity reactions. Allergin-1 Protein, Human (HEK293, His) is the recombinant human-derived Allergin-1 protein, expressed by HEK293 , with C-His labeled tag. The total length of Allergin-1 Protein, Human (HEK293, His) is 227 a.a., with molecular weight of ~24.8 kDa.

Cat. No.	Product Name	Chemical Structure

HY-17429S

Flecainide-d4 acetate
Flecainide-d₄ (acetate) is the deuterium labeled Flecainide acetate. Flecainide acetate (R-818) is a class 1C antiarrhythmic agent especially used for the management of supraventricular arrhythmia; works by blocking the Nav1.5 sodium channel in the heart, causing prolongation of the cardiac action potential[1][2].

HY-N0305S3

5-Aminolevulinic acid-13C-1 hydrochloride
5-Aminolevulinic acid- ¹³C-1 (5-ALA- ¹³C-1) hydrochloride is the ¹³C labeled 5-Aminolevulinic acid hydrochloride ^[1]. 5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) is an intermediate in heme biosynthesis in the body and the universal precursor of tetrapyrroles .

HY-B1449S2

Uridine-13C-1

Uridine- ¹³C-1 is the ¹³C labeled Uridine[1].
HY-I0400S1

N-Acetylneuraminic acid-13C-1

N-Acetylneuraminic acid- ¹³C-1 is the ¹³C labeled N-Acetylneuraminic acid.
HY-B0400AS1

L-Sorbitol-13C-1

L-Sorbitol- ¹³C-1 is the ¹³C labeled L-Sorbitol[1].
HY-W012584S1

L-Arabinopyranose-13C-1

L-Arabinopyranose- ¹³C-1 is the ¹³C labeled L-Arabinopyranose[1].
HY-W142434S

D-Galactose-13C-1

D-Galactose- ¹³C-1 is the ¹³C labeled D-galactopyranose[1].
HY-N6614S1

L-Galactose-13C-1

L-Galactose- ¹³C-1 is the ¹³C labeled L-Galactose[1].
HY-146994S1

L-Idose-13C-1

L-Idose- ¹³C-1 is the ¹³C labeled L-Idose[1].
HY-N0059AS1

L-(+)-Lyxose-13C-1

L-(+)-Lyxose- ¹³C-1 is the ¹³C labeled L-Lyxose[1].
HY-W016508S1

L-(-)-Mannose-13C-1

L-(-)-Mannose- ¹³C-1 is the ¹³C labeled L-(-)-Mannose[1].
HY-W145492S3

D-(+)-Talose-13C-1

D-(+)-Talose- ¹³C-1 is the ¹³C labeled D-(+)-Talose[1].
HY-W088065S1

Sodium formate-13C,d1

Sodium formate- ¹³C,d₁ is the deuterium and ¹³C labeled Sodium formate[1].

HY-B1213S

Trimipramine-d3 maleate
Trimipramine-d₃ (maleate) is the deuterium labeled Trimipramine maleate. Trimipramine maleate is a 5-HT receptor antagonist, with pKis of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively[1][2].

HY-77956S1

Thyminose-13C-1

Thyminose- ¹³C-1 is the ¹³C labeled Thyminose. Thyminose is an endogenous metabolite[1].
HY-150628S

2-Oxobutanoic acid-13C,d1 sodium hydrate

2-Oxobutanoic acid- ¹³C,d₁ sodium hydrate is the deuterium and ¹³C labeled 2-Oxobutanoic acid sodium hydrate.

HY-W048482S

rU Phosphoramidite-13C2,d1
rU Phosphoramidite- ¹³C₂,d₁ (DMT-2'O-TBDMS-rU phosphoramidite- ¹³C₂,d₁) is deuterium and ¹³C-labeled rU Phosphoramidite (HY-W048482). rU Phosphoramidite is a phosphorite monomer that can be used in the synthesis of oligonucleotides.

HY-128741S1

D-Allose-13C-1

D-Allose- ¹³C-1 is the ¹³C labeled D-Allose. D-Allose is an endogenous metabolite[1].
HY-N0059S1

D-Arabinose-13C-1

D-Arabinose- ¹³C-1 is the ¹³C labeled D-arabinose. D-arabinose is an endogenous metabolite[1].
HY-B1732S3

DL-3-Phenylalanine-13C-1

DL-3-Phenylalanine- ¹³C-1 is the ¹³C labeled DL-3-Phenylalanine[1].
HY-W039909S1

Tri-O-acetyl-D-galactal-13C-1

Tri-O-acetyl-D-galactal- ¹³C-1 is the ¹³C labeled Tri-O-Acetyl-D-galactose[1].

HY-14940S

Volinanserin-d4 hydrochloride
Volinanserin-d₄ (hydrochloride) is the deuterium labeled Volinanserin hydrochlorid. Volinanserin is a potent and selective antagonist of 5-HT2 receptor, with a Ki of 0.36 nM, and shows 300-fold selectivity for 5-HT2 receptor over 5-HT1c, alpha-1 and DA D2 receptors. Volinanserin has antipsychotic activity[1][2].

HY-125818S2

Cytidine-5'-triphosphate-13C,d1 dilithium

Cytidine-5'-triphosphate- ¹³C,d₁ (Cytidine triphosphate- ¹³C,d₁ dilithium; 5'-CTP- ¹³C,d₁) dilithium is deuterium and ¹³C-labeled Cytidine-5'-triphosphate (HY-125818). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule?in the de novo?pyrimidine biosynthetic pathway in?T. gondii.

HY-N7092S2

D-Fructose-13C-1

D-Fructose- ¹³C-1 is the ¹³C labeled D-Fructose. D-Fructose (D(-)-Fructose) is a naturally occurring monosaccharide found in many plants.
HY-W013378S5

Carbamazepine 10,11-epoxide-13C-1

Carbamazepine 10,11-epoxide- ¹³C-1 is the ¹³C labeled Carbamazepine 10,11-epoxide (HY-W013378)[1].
HY-Y0418S1

Dulcite-13C-1

Dulcite- ¹³C-1 is the ¹³C labeled Dulcite. Dulcite is a sugar alcohol with a slightly sweet taste which is a metabolic breakdown product of galact[1][2].
HY-B1659S2

Glycerol-13C-1

Glycerol- ¹³C-1 is the ¹³C labeled Glycerol. Glycerol is used in sample preparation and gel formation for polyacrylamide gel electrophoresis[1][2][3][4].
HY-N3686S1

D-Arabitol-13C-1

D-Arabitol- ¹³C-1 is the ¹³C labeled D-Arabitol. D-Arabitol is a polyol and its accumulation may cause a neurotoxic effect in hu[1][2].

HY-113143AS1

Galactose 1-phosphate-13C-1 potassium
Galactose 1-phosphate- ¹³C-1 (potassium) is the ¹³C labeled Galactose 1-phosphate Potassium salt. Galactose 1-phosphate Potassium salt is is an intermediate in the galactose metabolism and nucleotide sug[1][2].

HY-B2227BS3

Lactate-13C-1 sodium
Lactate- ¹³C-1 (sodium) is the ¹³C labeled Lactate (sodium)[1]. Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[2].

HY-W010042S1

L-Glucose-13C-1

L-Glucose- ¹³C-1 is the ¹³C labeled L-Glucose. L-Glucose (L-(-)-Glucose) is an enantiomer of D-glucose. L-Glucose can promote food intake[1][2].

HY-N0666S10

L-Aspartic acid-C13-1
L-Aspartic acid- ¹³C-1 is the deuterium labeled L-Aspartic acid[1]. L-Aspartic acid is is an amino acid, shown to be a suitable proagent for colon-specific agent deliverly[2][3].

HY-N1446S4

Oleic acid-13C-1
Oleic acid- ¹³C-1 is the ¹³C labeled Oleic acid. Oleic acid (9-cis-Octadecenoic acid) is an abundant monounsaturated fatty acid[1]. Oleic acid is a Na+/K+ ATPase activator[2].

HY-34628S1

Tri-O-acetyl-D-glucall-13C-1

3,4,6-Tri-O-acetyl-D-glucal- ¹³C-1 is the ¹³C labeled 3,4,6-Tri-O-acetyl-D-glucal[1].

HY-N0379S6

D-Mannose-13C-1
D-Mannose- ¹³C-1 is the ¹³C labeled D-Mannose. D-Mannose is a carbohydrate, which plays an important role in human metabolism, especially in the glycosylationof specific prote[1][2].

HY-W400722

Sodium 3-methyl-2-oxobutanoate-13C5,d1

Sodium 3-methyl-2-oxobutanoate- ¹³C₅,d₁ is the deuterium and ¹³C labeled Sodium 3-methyl-2-oxobutanoate[1].

HY-N1480S1

(-)-Fucose-13C-1
(-)-Fucose- ¹³C-1 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-B0158S2

Cytidine-13C-1
Cytidine- ¹³C-1 is the ¹³C labeled Cytidine. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholami

HY-111095S2

D-(-)-Lactic acid-13C-1
D-(-)-Lactic acid- ¹³C-1 is the ¹³C labeled D-(-)-Lactic acid. D-(-)-Lactic acid is a normal intermediate in the fermentation (oxidation, metabolism) of sugar. D-(-)-Lactic acid is identified to be a competitive inhibitor of ProDH (proline dehydrogenase) in plants ^[1].

HY-B0389S20

D-Glucose-13C,d-1
D-Glucose- ¹³C,d-1 is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical si

HY-Y0366S4

Lauric acid-13C-1
Lauric acid- ¹³C-1 is the deuterium labeled Lauric acid. Lauric acid is a middle chain-free fatty acid with strong bactericidal properties. The EC50s for P. acnes, S.aureus, S. epidermidis, are 2, 6, 4 μg/mL, respectively[1].

HY-42680S1

D-Tagatose-13C-1
D-Tagatose- ¹³C-1 is the ¹³C labeled D-Tagatose. D-Tagatose (D-(-)-Tagatose) is a rare monosaccharide found in nature with prebiotic characteristics. D-Tagatose is as a substitute for sucrose and a low-calorie sweetener in foodstuffs such as gum, fruit jui

HY-W042357S5

Ac-rC Phosphoramidite-13C,d1
Ac-rC Phosphoramidite- ¹³C,d₁ is deuterium and ¹³C-labeled Ac-rC Phosphoramidite (HY-W042357). Ac-rC Phosphoramidite is used for the oligoribonucleotide phosphorodithioate modification (PS2-RNA).

HY-128850S2

N-Acetyl-D-mannosamine-13C-1
N-Acetyl-D-mannosamine- ¹³C-1 is the ¹³C labeled N-Acetyl-D-mannosamine. N-Acetyl-D-mannosamine (ManNAc) is an essential precursor of N-acetylneuraminic acid (NeuAc), the specific monomer of bacterial capsular polysialic acid (PA)[1][2]

HY-W012864S1

(2S,3R)-2,3,4-Trihydroxybutanal-13C-1

(2S,3R)-2,3,4-Trihydroxybutanal- ¹³C-1 is the ¹³C labeled (2S,3R)-2,3,4-Trihydroxybutanal[1].

HY-B0400S2

D-Sorbitol-13C-1
D-Sorbitol- ¹³C-1 is the ¹³C labeled D-Sorbitol. D-Sorbitol (Sorbitol) is a six-carbon sugar alcohol and can used as a sugar substitute. D-Sorbitol can be used as a stabilizing excipient and/or isotonicity agent, sweetener, humectant, thickener and dietary

HY-W018772S2

D-Ribose-13C-1
D-Ribose- ¹³C-1 is the ¹³C labeled D-Ribose. D-Ribose is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose is active in protein glyca

HY-N1150S3

Thymidine-13C-1
Thymidine- ¹³C-1 is the ¹³C labeled Thymidine. Thymidine, a specific precursor of deoxyribonucleic acid, is used as a cell synchronizing agent. Thymidine is a DNA synthesis inhibitor that can arrest cell at G1/S boundary, prior to DNA replication[1]

HY-W042357S3

Ac-rC Phosphoramidite-13C2,d1
Ac-rC Phosphoramidite- ¹³C₂,d₁ is deuterium and ¹³C-labeled Ac-rC Phosphoramidite (HY-W042357). Ac-rC Phosphoramidite is used for the oligoribonucleotide phosphorodithioate modification (PS2-RNA).

HY-A0132S2

N-Acetyl-D-glucosamine-13C-1
N-Acetyl-D-glucosamine- ¹³C-1 is the ¹³C labeled N-Acetyl-D-glucosamine. N-Acetyl-D-Glucosamine (N-Acetyl-2-amino-2-deoxy-D-glucose) is a monosaccharide derivative of gluc[1][2].

Cat. No.	Product Name		Classification

HY-140009

Azido-PEG1-C2-acid		PROTAC Synthesis Azide
Azido-PEG1-C2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs ^[1]. Azido-PEG1-C2-acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

HY-130690

Propargyl-PEG1-SS-PEG1-C2-Boc		Alkynes PROTAC Synthesis ADC Synthesis
Propargyl-PEG1-SS-PEG1-C2-Boc is a Alkyl/ether-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG1-SS-PEG1-C2-Boc is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) ^[1]. Propargyl-PEG1-SS-PEG1-C2-Boc is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.